Comparing two imaging methods for guiding minimally invasive liver cancer surgery

This trial is testing whether a special fluorescent dye called ICG (indocyanine green) can help surgeons more safely and effectively remove liver cancer using minimally invasive laparoscopic surgery. Researchers want to compare two different ways of injecting this dye — through an artery versus through the portal vein — to see which method helps surgeons better identify and remove cancerous tissue while preserving healthy liver.

Liver cancer surgery is challenging because surgeons need to remove the cancer completely while keeping as much healthy liver as possible. This fluorescent imaging technique is a newer tool that might help surgeons see tumor boundaries more clearly during minimally invasive surgery, but doctors need to determine which injection method works best and produces the best outcomes for patients.